Reckitt Benckiser Group (LON:RKT – Get Free Report) had its price objective raised by investment analysts at JPMorgan Chase & Co. from GBX 5,800 to GBX 6,500 in a research note issued on Tuesday, London Stock Exchange reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 21.27% from the company’s current price.
A number of other analysts have also recently weighed in on the company. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a GBX 5,400 price target on shares of Reckitt Benckiser Group in a research report on Thursday, July 30th. Royal Bank Of Canada reissued a “sector perform” rating and issued a GBX 6,200 price objective on shares of Reckitt Benckiser Group in a research note on Wednesday, July 29th. Jefferies Financial Group restated a “buy” rating and issued a GBX 5,900 target price on shares of Reckitt Benckiser Group in a report on Wednesday, July 29th. Finally, Berenberg Bank increased their price target on Reckitt Benckiser Group from GBX 5,179 to GBX 5,352 and gave the company a “hold” rating in a report on Wednesday, August 5th. Four equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of GBX 6,178.86.
View Our Latest Stock Analysis on RKT
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group (LON:RKT – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported GBX 101.40 earnings per share for the quarter. Reckitt Benckiser Group had a net margin of 21.09% and a return on equity of 42.87%. As a group, research analysts expect that Reckitt Benckiser Group will post 331.2110727 EPS for the current fiscal year.
Insider Activity at Reckitt Benckiser Group
In related news, insider Gavin Patterson purchased 191 shares of the firm’s stock in a transaction on Wednesday, August 26th. The shares were bought at an average cost of GBX 5,183 per share, for a total transaction of £9,899.53. Also, insider Shannon Eisenhardt acquired 432 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were bought at an average cost of £432 per share, with a total value of £186,624. Over the last ninety days, insiders acquired 1,032 shares of company stock worth $21,636,131. 0.45% of the stock is owned by insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
